What does Coologics do?
Coologics specializes in sustainable healthcare treatments by developing drug-free solutions that address antibiotic resistance. Its flagship product, Vlisse, is a patented intravaginal cooling device designed to treat vaginal infections by restoring a healthy vaginal environment.
How much did they raise?
The company raised $3M in a Seed funding round led by Prevail and Dream Ventures, with additional participation from Ohio State Early Investor Network and Illinois Ventures Illini Angels Program.
What are their plans for the money?
The funds will be used to accelerate the clinical trial, prepare the FDA submission, and support the initial market release of Vlisse, potentially transforming treatment options for vaginal infections.
What have they achieved so far?
Coologics has already initiated clinical trials for Vlisse, demonstrating progress towards offering a drug-free alternative for managing vaginal infections and addressing the challenges of antibiotic resistance.
